Similar articles

• [Sponsorship of medical congresses, workshops and symposia by pharmaceutical companies].

  Warntjen M. Warntjen M. Pathologe. 2010 Mar;31(2):157-61. doi: 10.1007/s00292-010-1279-0. Pathologe. 2010. PMID: 20198463 German. No abstract available.
• [Sponsoring of medical congresses: a unproblematic problem?].

  Melzer S. Melzer S. Unfallchirurg. 2010 Feb;113(2):164. doi: 10.1007/s00113-010-1750-7. Unfallchirurg. 2010. PMID: 20108083 German. No abstract available.
• Regulation of clinical research sponsored by pharmaceutical companies: a proposal.

  Sotelo J. Sotelo J. PLoS Med. 2006 Jul;3(7):e306. doi: 10.1371/journal.pmed.0030306. PLoS Med. 2006. PMID: 16805651 Free PMC article.
• Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.

  Schetky DH. Schetky DH. Child Adolesc Psychiatr Clin N Am. 2008 Jan;17(1):113-25, ix-x. doi: 10.1016/j.chc.2007.07.007. Child Adolesc Psychiatr Clin N Am. 2008. PMID: 18036482 Review.
• [Criminal implication of sponsoring in medicine: legal ramifactions and recommendations].

  Mahnken AH, Theilmann M, Bolenz M, Günther RW. Mahnken AH, et al. Rofo. 2005 Aug;177(8):1070-6. doi: 10.1055/s-2005-858331. Rofo. 2005. PMID: 16021538 Review. German.